Blackstone closes its largest Asia-focused private equity fund at $13.1 billion, according to multiple outlets. The fund, named Blackstone Capital Partners Asia III, is Blackstone’s latest regional vehicle targeting investments across Asia. Reports say Blackstone originally targeted about $10 billion for this fund and ultimately raises more than double its previous related vehicle size. CNBC notes the close at more than $13 billion and describes it as the largest private equity fundraise the firm has completed in the region. Other coverage similarly states that the fund raises $13.1 billion and emphasizes that it is Blackstone’s biggest Asia fund to date. Seeking Alpha and Channel NewsAsia also report the $13.1 billion figure for Blackstone Capital Partners Asia III. No outlet in the provided excerpts specifies the fund’s investor base, geography by country, or sector focus, beyond describing it as Blackstone’s largest Asia private equity vehicle.
Blackstone raises $13.1 billion for its largest Asia private equity fund
Blackstone closes its largest Asia-focused private equity fund at $13.1 billion, according to multiple outlets. The fund, named Blackstone Capital Partners Asia III, is Blackstone’s latest regional ve...
- Blackstone Capital Partners Asia III closes with $13.1 billion in committed capital.
- The fund is Blackstone’s largest Asia private equity fund.
- Blackstone reportedly targets about $10 billion for the fund but raises more than that.
- Several outlets describe the fundraising as record-setting for Blackstone in Asia.
- The reports frame the closing as part of Blackstone’s broader private equity expansion in the region.
Blackstone raised $13.1 billion for its latest Asia private equity vehicle, marking the largest private equity fundraise the firm has done in the region.
2 months agoBlackstone, which was targeting $10 billion for the fund named Blackstone Capital Partners Asia III, said it has raised more than double the amount of its previous vehicle
2 months ago
Capricor Therapeutics faces securities fraud class action; lead plaintiff deadline set for Sept. 28, 2026
Capricor Therapeutics, Inc. (NASDAQ: CAPR) is named in a securities class action that alleges the company misled investo...
Centre appoints directors and joint director to NTA amid NEET controversies and reforms
The Centre appoints two directors and a joint director to the National Testing Agency (NTA), according to personnel mini...
Trump’s 50% tariffs on Canadian goods take effect, covering hundreds of items
The United States is implementing new 50% tariffs on imports from Canada, which take effect immediately and apply to a b...